These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19000546)

  • 1. Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting--a case report and review of the literature.
    Woznowski M; Quack I; Stegbauer J; Büchner N; Rump LC; Schieren G
    Clin Nephrol; 2008 Nov; 70(5):431-8. PubMed ID: 19000546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic Secretion of Multiple Phosphatonins From a Deep Fibrous Histiocytoma Causing Oncogenic Osteomalacia.
    Leow MKS; Dogra S; Ge X; Chuah KL; Liew H; Loke KSH; McFarlane C
    J Clin Endocrinol Metab; 2021 Apr; 106(5):e2299-e2308. PubMed ID: 33462615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
    Fukumoto S; Takeuchi Y; Nagano A; Fujita T
    Bone; 1999 Sep; 25(3):375-7. PubMed ID: 10495143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced osteomalacia.
    Jan de Beur SM
    JAMA; 2005 Sep; 294(10):1260-7. PubMed ID: 16160135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-induced osteomalacia: a literature review and a case report.
    Dadoniene J; Miglinas M; Miltiniene D; Vajauskas D; Seinin D; Butenas P; Kacergius T
    World J Surg Oncol; 2016 Jan; 14(1):4. PubMed ID: 26744291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual paraneoplastic syndromes: small cell lung carcinoma-related oncogenic osteomalacia, and syndrome of inappropriate antidiuretic hormone secretion: report of a case and review of the literature.
    Tantisattamo E; Ng RC
    Hawaii Med J; 2011 Jul; 70(7):139-43. PubMed ID: 21886301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor localization and treatment of tumor-induced osteomalacia].
    Beil FT; Stürznickel J; Rolvien T; Amling M; Oheim R
    Z Rheumatol; 2022 Apr; 81(3):182-188. PubMed ID: 35103802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypophosphatemic osteomalacia].
    Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
    Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia.
    Habra MA; Jimenez C; Huang SC; Cote GJ; Murphy WA; Gagel RF; Hoff AO
    Endocr Pract; 2008 Dec; 14(9):1108-14. PubMed ID: 19158050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-induced osteomalacia.
    Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
    Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenging case of tumour-induced osteomalacia.
    Kumar P; Jadhav DV; Ravat SH; Jain N
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35589273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
    Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
    Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare combination of tumor-induced osteomalacia caused by sinonasal glomangiopericytoma and coexisting parathyroid adenoma: case report and literature review.
    Brociek-Piłczyńska A; Brodowska-Kania D; Szczygielski K; Lorent M; Zieliński G; Kowalewski P; Jurkiewicz D
    BMC Endocr Disord; 2022 Jan; 22(1):31. PubMed ID: 35090436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor induced osteomalacia from a peripheral mesenchymal tumour of the foot.
    Strydom A; Greeff W; Ferrao PNF; Saragas NP
    Foot (Edinb); 2023 May; 55():101979. PubMed ID: 36871520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Phosphatonins" and the regulation of phosphorus homeostasis.
    Berndt TJ; Schiavi S; Kumar R
    Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1170-82. PubMed ID: 16275744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent urinary phosphate wasting in a patient with metastatic breast cancer: What's your diagnosis?
    Bhasin B; Velez JCQ
    Clin Nephrol; 2021 Feb; 95(2):99-103. PubMed ID: 33141014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.